44
Participants
Start Date
April 14, 2021
Primary Completion Date
May 23, 2023
Study Completion Date
May 23, 2023
SLN124
SLN124 for subcutaneous (s.c.) injection
Placebo
Sodium chloride for s.c. injection
Universitaetsklinikum Duesseldorf, Düsseldorf
Universitat Leipzig, Leipzig
Rambam Health Care Campus, Haifa
Sheba Medical Center, Ramat Gan
Bar-Ilan University - Faculty of Medicine, Safed
Tel Aviv Sourasky Medical Center, Tel Aviv
AUSL della Romagna - Ospedale di Ravenna, Ravenna
Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia
Jordan University Hospital, Amman
King Hussein Cancer Center, Amman
Irbid Speciality Hospital, Irbid
Sarawak General Hospital, Kampung Sarawak
Hospital Ampang, Kampung Selangor
King Chulalongkorn Memorial Hospital, Bangkok
Mahidol University - Faculty of Medicine - Ramathibodi Hospital, Bangkok
Mahidol University - Siriraj Hospital, Bangkok
Faculty of Medicine, Chiang Mai University, Chiang Mai
University Hospital of Wales, Cardiff
The Leeds Teaching Hospitals NHS Trust - Saint James's University Hospital, Leeds
Hammersmith Medicines Research Ltd (HMR), London
Silence Therapeutics plc
INDUSTRY